Phase 3 study designed with total hip BMD primary endpoint assessed at 12 months, rather than at 24 months EB613 single ...
AZTR READ THE FULL AZTR RESEARCH REPORT Azitra, Inc. (NYSE:AZTR) reported full year 2025 financial and operational results in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results